GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) shares rose 40.4% on Thursday . The stock traded as high as $0.18 and last traded at $0.17. Approximately 7,345 shares changed hands during trading, a decline of 55% from the average daily volume of 16,415 shares. The stock had previously closed at $0.12.
GeoVax Labs Stock Performance
The firm has a fifty day moving average price of $0.12 and a two-hundred day moving average price of $0.16.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Further Reading
- Five stocks we like better than GeoVax Labs
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Manufacturing Stocks Investing
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
